Gene vector regulation by cardiomyocyte-expressed microRNAs
JP7865533B2Active Publication Date: 2026-05-26TENAYA THERAPEUTICS INC
View PDF 8 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- TENAYA THERAPEUTICS INC
- Filing Date
- 2021-02-26
- Publication Date
- 2026-05-26
Smart Images

Figure 0007865533000025 
Figure 0007865533000026 
Figure 0007865533000027
Abstract
The present disclosure provides vectors and methods of use thereof for cell-type-specific repression of transgene (e.g., cardiomyocyte reprogramming factor) expression using microRNA binding sites. The present invention generally relates to vectors and methods of use thereof for cell-type-specific repression of transgene (e.g., cardiomyocyte reprogramming factor) expression. The present disclosure provides vectors comprising microRNA binding sites configured to promote specific repression of transgene (e.g., cardiomyocyte reprogramming factor) expression in cardiomyocytes and cardiac progenitor cells relative to cardiac fibroblasts.
Need to check novelty before this filing date? Find Prior Art